Home > Press > Gateway Park Announces Lease to RXi Pharmaceuticals
Company Founded by 2006 Nobel Prize co-recipient Dr. Craig Mello to Lease Space
Gateway Park Announces Lease to RXi Pharmaceuticals
WORCESTER, MA | Posted on October 23rd, 2007
Gateway Park announced today that RXi Pharmaceuticals has signed a 20-month lease to locate in the WPI Life Sciences and Bioengineering Center with the option to become the lead tenant of a future 100,000-square-foot building planned for construction at Gateway Park. The company, founded by Nobel Laureate Craig Mello, PhD, is one of several firms that have signed an Indication of Interest as potential future tenants of the rapidly expanding Gateway Park.
RXi Pharmaceuticals was created to develop therapeutics for the treatment of human disease employing the RNA interference (RNAi) technology co-discovered by Dr. Mello, of the University of Massachusetts Medical School. RNAi technology can help determine the function of particular genes in the body and also potentially lead to the development of new RNAi-based drugs. Using RNAi to turn off defective genes opens the door for an entirely new class of drugs to potentially treat cancer, diabetes, Alzheimer's, ALS, and many other diseases.
According to D'Anne Hurd, Vice President for Business Development at Gateway Park, "Gateway Park offered all of the advantages RXi Pharmaceuticals was looking for in a location - state-of-the-art laboratories, beautiful office space, access to shared equipment, support infrastructure, and proximity to their founding scientist's laboratories in Worcester, MA."
As a tenant in the new Life Sciences and Bioengineering Center, RXi Pharmaceuticals will be adjacent to dozens of WPI faculty members and students, working in interdisciplinary research centers and programs, who are conducting basic and applied research and working to translate their discoveries into viable life-sciences-based products and companies. The WPI Life Sciences and Bioengineering Center is the first building to be completed at Gateway Park and it hosts advanced research in such areas as regenerative medicine, molecular nanotechnology and biosensors, plant systems, tissue engineering, and untethered healthcare.
"RXi is an ideal match for what Gateway Park can provide to growing, creative life sciences companies," said WPI President and CEO Dennis Berkey. "We are honored that RXi Pharmaceuticals is interested in joining the unique community of scientists, entrepreneurs and innovators at Gateway Park. Their interest in becoming the lead tenant of the 100K sq ft. building is a testament to the growing momentum at Gateway Park."
About RXi Pharmaceuticals
RXi is a biopharmaceutical research and development company that focuses on developing RNAi-based therapeutics for the treatment of human disease. The company was founded by RNAi pioneers Craig Mello, Ph.D., 2006 Nobel Laureate for discovering RNAi and inventing RNAi therapeutics, Tariq M. Rana, Ph.D., inventor of fundamental technology for stabilizing RNAi and of RNAi nanotransporters, Greg Hannon, Ph.D., discoverer of RNAi mechanism (RISC) and short hairpin RNAi (shRNAi), and Michael Czech, Ph.D., a leader in the application of RNAi to diabetes and obesity. Mello, Rana and Czech are on the faculty at the University of Massachusetts Medical School in Worcester, MA; Hannon is at Cold Spring Harbor Laboratory in New York.
About Gateway Park
Gateway Park is a joint venture of Worcester Polytechnic Institute (WPI) and the Worcester Business Development Corporation (WBDC). Located in Worcester, near the intersection of I-190 and I-290, Gateway Park is designed as a 12 acre, mixed-use destination for life sciences and biotech companies and the people who work for them. At completion, the project will include five life sciences buildings totaling 500,000 square feet of flexible, adaptable lab space designed to meet the needs of research organizations, 241,000 sq. ft. of market rate, loft condominiums as well as several planned retail establishments. WPI is also exploring the possibility of graduate student housing on one of the sites. Gateway Park is part of the larger 55-acre Gateway redevelopment district. It is currently home to numerous businesses, offices, restaurants, and business services, as well as a Courtyard by Marriott hotel.
About Worcester Polytechnic Institute
Founded in 1865 in Worcester, Mass., WPI was one of the nation's first engineering and technology universities. WPI's 18 academic departments offer more than 50 undergraduate and graduate degree programs in science, engineering, technology, management, the social sciences, and the humanities and arts, leading to the BA, BS, MS, ME, MBA and PhD. WPI's world-class faculty work with students in a number of cutting-edge research areas, leading to breakthroughs and innovations in such fields as biotechnology, fuel cells, and information security, materials processing, and nanotechnology. Students also have the opportunity to make a difference to communities and organizations around the world through the university's innovative Global Perspective Program. There are more than 20 WPI project centers throughout North America and Central America, Africa, Australia, Asia, and Europe.
For more information, please click here
Eileen Brangan Mell
Director of Public Relations
Copyright © Worcester Polytechnic Institute
If you have a comment, please Contact
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
JPK announces expansion of its global sales and service activities in China and USA April 15th, 2014
Thailand's Next Move on Research and Innovation March 11th, 2014
Beneq and LETI open ALD-dedicated research laboratory in St. Petersburg November 18th, 2013
NTU sets up Southeast Asia’s first nanomedicine research institute - New $60 million institute to focus on diabetes, cardiovascular, ophthalmology and skin therapeutics November 6th, 2013
Oxford Instruments Asylum Research Introduces the MFP-3D InfinityTM AFM Featuring Powerful New Capabilities and Stunning High Performance April 18th, 2014
High-temperature plasmonics eyed for solar, computer innovation April 17th, 2014
INSCX™ exchange to present Exchange trade reporting mechanism for engineered nanomaterials (NMs) to UK regulation agencies, insurers and upstream/downstream users April 17th, 2014
Transparent Conductive Films and Sensors Are Hot Segments in Printed Electronics: Start-ups in these fields show above-average momentum, while companies working on emissive displays such as OLED are fading, Lux Research says April 17th, 2014